CASE STUDY

Accelerated Cancer Target ID by 75% with ML & Curated Data

Key Highlights

  • The company aimed to find targets for differentiation therapy for cancers including AML.
  • Data retrieval, harmonization and ML model development are time-consuming.
  • To help the company circumvent the time factor, Elucidata curated an omics data atlas and developed custom pipelines.
  • The company was able to identify two targets in 2-3 months compared to the 1-2 years that it generally takes.
Get your case study now
Please enter only business email ids.
Thank you for showing interest!

To know more about us, book a demo here.
Oops! Something went wrong while submitting the form.

All Case Studies

Case study: Accelerated Target ID using ML-Ready data on Polly

Data Interoperability as a Service: 6X Faster Clinico-Genomic Data Integration & Analysis with Polly

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Elucidata Cuts 95% Manual Scientist Effort in Protein Production Workflows

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Predicting Spatially Resolved Gene Expression from Histopathology Images

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

500 Hours Of Data Wrangling Saved While Ensuring Superior Data Quality

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

80% Faster Data Management & 50% Fewer Data Queries for Academic Core Facilities

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Six Months to Success: Accelerating AML Target-indication Assessment With Advanced Knowledge Graphs

Read More
Request Demo